Skip to main content

Sienna Chapter 11 Bankruptcy Proceeding:

On September 17, 2019, Sienna announced that it had elected to file a voluntary petition to allow restructuring under Chapter 11 of the Bankruptcy Code. All pleadings filed in Sienna’s Chapter 11 proceedings are maintained on the case docket for Sienna Biopharmaceuticals, Inc., Case No. 19-12051, which can be accessed through the website maintained by the United States Bankruptcy Court for the District of Delaware ( or an unofficial version of the case docket along with other case information is available at

Press Releases

There are currently no news releases to display.

SEC Filings


There are currently no events to display.

Webcast events that have already occurred are presented for historical purposes only and speak only as of the date thereof.

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Refresh quote

Analyst Coverage

Firm Analyst
J.P. Morgan
Chris Schott
Ken Cacciatore

The analysts above have initiated and are maintaining formal research coverage of Sienna. Please note that any opinions, estimates or forecasts regarding Sienna’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Sienna or Sienna’s management. Sienna does not by reference above or distribution of same imply endorsement of or concurrence with any analyst’s opinions, estimates, forecasts, conclusions or recommendations. Sienna does not participate in the preparation of analysts’ reports and undertakes no obligation to verify or correct any information in such reports.

Transfer Agent

EQ Shareowner Services

IR Contact

Media Contact